NI, YONG,PARIKH, BHAVNISH,YELESWARAM, KRISHNASWAMY,ERICKSON-VIITANEN, SUSAN,WILLIAMS, WILLIAM V.
申请号：
SG11201503695X
公开号：
SG11201503695XA
申请日:
2013.11.14
申请国别(地区):
SG
年份:
2015
代理人:
摘要：
The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
